Integra LifeSciences | Umlaufvermögen



Current Assets Veränderung Datum
Abbott USD 23.66B 146M 2024-12
AtriCure USD 267.83M 1.46M 2024-12
Baxter International USD 8.85B 11M 2024-12
Becton, Dickinson and Co. USD 8.66B 1.81B 2024-12
Boston Scientific USD 6.92B 1.84B 2024-12
CONMED USD 640.01M 992K 2024-12
Cooper Companies USD 1.99B 35.5M 2025-01
Dexcom USD 4.3B 38.6M 2024-12
Edwards Lifesciences USD 6.29B 442.3M 2024-12
Globus Medical USD 2.18B 120.73M 2024-12
Hologic USD 3.49B 329.7M 2024-12
Insulet USD 1.89B 30.4M 2024-12
Integra LifeSciences USD 1.08B 17.84M 2024-12
Intuitive Surgical USD 11.54B 4.33B 2024-12
J&J USD 55.89B 2.64B 2024-12
Medtronic USD 22.51B 75M 2025-01
Merit Medical Systems USD 923.77M 154.54M 2024-12
Smith & Nephew USD 4.42B 37M 2024-12
Stryker USD 14.85B 174M 2024-12
Tandem Diabetes Care USD 724.49M 28.33M 2024-12
Teleflex USD 1.47B 28.18M 2024-12
Zimmer Biomet Holdings USD 4.67B 192.5M 2024-12



Integra LifeSciences Umlaufvermögen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.